Plastics Products, NEC
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through three segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. The company provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. It also sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. In addition, the company offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company primarily sells its products and services through its own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Discounted Cash Flow Valuation of Aptargroup, Inc.
Growth
%
%
Discount
%
%
Multiple
g\r | +10% | +11% | +12% | +13% | +14% |
---|---|---|---|---|---|
0% | 10 | 9 | 8 | 8 | 7 |
+1% | 11 | 10 | 9 | 8 | 8 |
+2% | 13 | 11 | 10 | 9 | 8 |
+3% | 14 | 13 | 11 | 10 | 9 |
+4% | 17 | 14 | 12 | 11 | 10 |
Years | 0 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | TV |
---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF | $259.1M | $255.5M | $251.9M | $248.3M | $244.8M | $241.4M | $238M | $234.7M | $231.4M | $228.1M | $224.9M | $2.249B |
DCF | $222.1M | $190.4M | $163.3M | $140M | $120M | $102.9M | $88.22M | $75.64M | $64.85M | $55.6M | $556M | |
Value | $1.779B |
In the chart Earnings are multiplied by this value.
High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.
Years | 12-2015 | 12-2016 | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Net Margin | 8.6% | 8.8% | 8.9% | 7% | 8.5% | 7.3% | 7.5% | 7.2% | 8.1% | 8.8% |
ROA | 13% | 12% | 10% | 8.5% | 10% | 8.5% | 8.4% | 9% | 9.1% | 9.7% |
ROE | 17% | 18% | 17% | 14% | 15% | 12% | 12% | 12% | 12% | 13% |
The average Net Margin over the past 5 years is +7.62%.
The trend of Net Margin over the past 5 years is +0.06%.
The average ROA over the past 5 years is +8.98%.
The trend of ROA over the past 5 years is -0.04%.
The average ROE over the past 5 years is +12.79%.
The trend of ROE over the past 5 years is -0.51%.
Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.
Years | 12-2015 | 12-2016 | 12-2017 | 12-2018 | 12-2019 | 12-2020 | 12-2021 | 12-2022 | 12-2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|
Debt FCF | 4.94 | 4.78 | 7.84 | 12.63 | 4.48 | 3.66 | 21.56 | 7.67 | 5.45 | 4.72 |
Debt Equity | 0.75 | 0.81 | 1.00 | 0.91 | 0.78 | 0.64 | 0.60 | 0.62 | 0.62 | 0.52 |
MIN | ||||||||||
Graham Stability | - | - | 100% | 93% | 100% | 98% | 100% | 100% | 100% | 93% |
The Debt/FCF trailing twelve month is 4.72.
The trend of Debt/FCF over the past 5 years is -0.24.
Graham’s Stability measure stands at 0.93.
Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.
Years | 12-2016 | 12-2018 | 12-2020 | 12-2022 | Trend |
---|---|---|---|---|---|
Revenue | 5.9% | 4.8% | 6% | 5% | 1.2% |
Net Income | 4.7% | 7.9% | 9.9% | 19% | 0.96% |
Stockholders Equity | 10% | 10% | 7.8% | 12% | 0.65% |
FCF | 4.1% | 21% | -6.7% | 56% | 11% |
The Revenue CAGR over the past 5 years is +4.75%.
The trend of Revenue growth rate over the past 5 years is +1.15%.
The Earnings CAGR over the past 5 years is +7.85%.
The trend of Earnings growth rate over the past 5 years is +0.96%.
The Equity CAGR over the past 5 years is +10.28%.
The trend of Equity growth rate over the past 5 years is +0.65%.
The FCF CAGR over the past 5 years is +20.76%.
The trend of FCF growth rate over the past 5 years is +10.97%.